Colonial Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Colonial Trust's ELV Position: Q2 2026 in Review
Colonial Trust reduced its Elevance Health (ELV) stake by 63% in Q2 2026, selling an estimated $191K and leaving 305 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #367.
Colonial Trust first reported a position in ELV in Q3 2022 and has held it in 16 quarters since. The position peaked at $675K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Colonial Trust held 305 shares of Elevance Health worth $118K as of Q2 2026.
- Colonial Trust sold 515 Elevance Health shares in Q2 2026, an estimated $191K.
- Elevance Health made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #367 holding.
- Colonial Trust first reported a position in Elevance Health in Q3 2022 and has held it in 16 quarters since.
- Colonial Trust's Elevance Health position peaked at $675K in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.